{"url_path":"/sec/cik-0001900520/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1900520/0001213900-26-057605-index.html","accession_number":"0001213900-26-057605","cik":"0001900520","ticker":null,"issuer_name":"Lomond Therapeutics Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1900520/0001213900-26-057605-index.html","primary_entity_key":"0001900520","primary_entity_name":"Lomond Therapeutics Holdings, Inc."},"word_count":63,"has_tables":true,"body_markdown":"**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**\n\n \n\n*Recent Sales of Unregistered Securities*\n\n \n\nDuring the quarter ended March 31, 2026, there\nwere no unregistered sales of our securities that were not reported in a Current Report on Form 8-K.\n\n \n\n*Repurchases*\n\n \n\nThe Company did not repurchase any of the Company’s\noutstanding equity securities during the three months ended March 31, 2026."}